Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression

Despite decades of research efforts and multiple clinical trials aimed at discovering efficacious disease-modifying osteoarthritis (OA) drugs (DMOAD), we still do not have a drug that shows convincing scientific evidence to be approved as an effective DMOAD. It has been suggested these DMOAD clinica...

Full description

Bibliographic Details

Published in:	Therapeutic Advances in Musculoskeletal Disease
Main Authors:	Ali Guermazi, Frank W. Roemer, Michel D. Crema, Mohamed Jarraya, Ali Mobasheri, Daichi Hayashi
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-04-01
Online Access:	https://doi.org/10.1177/1759720X231165558